Etudes réalisées et publiées (ou sous presse)
Présentées par domaine d’activité 

Revues internationales à comité de lecture:

Transplantation
  • Courivaud C, Bamoulid J, Loupy A, Deschamps M, Ferrand C, Le Corre D, Tiberghien P, Chalopin JM, Legendre C, Thervet E, Saas P, Ducloux D.
    Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism -765 on graft loss after renal transplantation.
    Am J Transplant, In press
  • Courivaud C, Bamoulid J, Tiberghien P, Chalopin JM, Legendre C, Thervet E, Saas P, Ducloux D
    G-765C COX-2 gene promoter polymorphism and risk of atherosclerosis after kidney transplantation.
    Transplantation, In press
  • Guichard G, Rebibou JM, Ducloux D, Simula-Faivre D, Tiberghien P, Chalopin JM, Bittard H, Saas P, Kleinclauss F
    Lymphocytes subsets in renal transplant recipients with de novo genitourinary malignancies.
    Urol. Int., 2008, 80: 257-63
  • Eljaafari A, Badet L, Kanitakis J, Ferrand C, Farre A, Petruzzo P, Morelon E, Dubosson M, Tiberghien P, Dubois V, Martin X, Miossec P, Dubernard JM
    Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation.
    Transplantation, 2006, 82: 1764-8
  • Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D
    The interleukin-6 promoter polymorphism-174 is associated with new onset diabetes after transplantation.
    J. Am. Soc. Nephrol., 2006, 17:2333-40
  • Courivaud C, Ferrand C, Deschamps M, Tiberghien P, Chalopin JM, Duperrier A, Saas P, Ducloux D
    No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation.
    Transplantation, 2006, 81:1212-1215
  • Yannaraki M, Rebibou JM, Ducloux D, Saas P, Duperrier A, Felix S, Rifle G, Chalopin JM, Hervé P, Tiberghien P, Ferrand C
    Urinary cytotoxic molecular markers for a non-invasive diagnosis in acute renal transplant rejection.
    Transplant. Int., 2006, 19:759-68
Rhumatologie
  • Toussirot E, Saas P (co-first author), Deschamps M, Pouthier F, Perrot L, Perruche S, Chabod J, Tiberghien P, Wendling D.
    Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity
    Arthritis Res. Ther., In press
  • Toussirot E, Dumoulin G, Saas P, Nguyen NU, Le Huédé G, Wendling D
    Increased tartrate-resistant acid phosphatase serum levels in Ankylosing Spondylitis and relationship with the inflammatory process.
    Ann. Rheum. Dis., 2008, 67:430-1
  • Toussirot E, Streit G, Nguyen NU, Dumoulin G, Le Huédé G, Saas P, Wendling D
    Adipose tissue, serum adipokines and ghrelin in patients with ankylosing spondylitis.
    Metabolism, 2007, 56: 1383-9
  • Toussirot E, Robinet E, Saas P, Chabod J, Augé B, Cozma G, Tiberghien P, Roudier J, Wendling D
    Bacterial extract (OM-89) specific and non specific immunomodulation in rheumatoid arthritis patients.
    Autoimmunity, 2006, 39: 299–306
Thérapie cellulaire-génique/hématopoïèse
  • Bennour E, Ferrand C, Rémy-Martin JP, Certoux JM, Gorke S, Qasim W, Gaspar HB, Baumert T, Duperrier A, Deschamps M, Fehse B, Tiberghien P, Robinet E.
    Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.
    Hum Gene Ther., 2008, 19: 699-709
  • Mercier-Letondal P, Deschamps M, Sauce D, Certoux JM, Milpied N, Lioure B, Cahn JY, Deconinck E, Ferrand C, Tiberghien P, Robinet E.
    Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?
    Hum. Gene Ther., 2008, 19: 937-50
  • Deschamps M, Robinet E, Certoux JM, Mercier P, Sauce D, De Vos J, Montcuquet N, Bonyhadi M, Reme T, Tiberghien P, Ferrand C
    Transcriptome of retrovirally transduced CD8(+) lymphocytes : Influence of cell activation, transgene integration, and selection process.
    Mol. Immunol., 2008, 45: 1112-25
  • Deschamps M, Mercier P, Certoux JM, Henry C, Lioure B, Pagneux C, Cahn JY, Deconinck E, Tiberghien P, Robinet E, Ferrand C
    Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T-cells infused with a hematopoietic graft.
    Blood, 2007, 110: 3842-52
  • Lapierre V, Pellegrini N, Bardey I, Malugani C, Saas P, Garnache F, Racadot E, Maddens S, Schillinger F
    Cord blood volume reduction using an automated system (sepax) versus a semi-automated system (Optipress II) versus a manual method (Hydroxyethyl starch sedimentation) for routine cord blood banking : a comparative study.
    Cytotherapy, 2007, 9:165-9
  • Brugniaux JV, Schmitt L, Robach P, Nicolet G, Fouillot JP, Moutereau S, Lasne F, Pialoux V, Saas P, Chorvot MC, Cornolo J, Olsen NV, Richalet JP
    Eighteen days of living high training low stimulate erythropoiesis and enhance aerobic performance in elite middle-distance runners.
    J. Appl. Physiol., 2006, 100:203-11
Maladie Résiduelle/Hématologie
  • Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadié M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V, Macintyre E, Bene MC, Saas P (co-senior author), Jacob MC, a GOELAMS and GEIL study.
    Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
    Br J Haematol. In press.

  • Robillard N, Cave H, Mechinaud F, Guidal C, Garnache-Ottou F, Rohrlich PS, Avet-Loiseau H, Garand R
    Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia.
    Haematologica, 2005, 90: 1516-23.

Abstracts (Congrès internationaux)

  • 70th Annual Scientific Meeting of the American-College-of-Rheumatology
    Toussirot E, Saas P, Pouthier F, Chabod J, Wendling D
    Increased levels of soluble CTLA-4 molecule in serum of patients with spondylarthropathies.
    Arthritis and Rheumatism, 2006, 54(9suppl): S467-S467.
  • 50th Annual Sientific Meeting of the American Society of Hematology
    Marmier-Savet C, Deconinck E, Larosa F, Mathieu-Nafissi S, Legrand F, Witz B, Bonmati C, Ranta D, Tavernier M, Michallet M, Louvat P, Puyraveau M, Raus N, Hequet O, Witz F, Collonge Rame MA, Pouthier F, Bresson JL, Tiberghien P, Robinet E
    Immune and Cytogenetic Perturbations after G-CSF Mobilization in Normal Peripheral Blood Stem Cell Donors.
    Blood, 2008; 112(suppl): 205.
  • Deschamps M, Henry C, Robinet E, Garnache-Ottou F, Remy-Martin JP, Borg C, Rohrlich PS, Deconinck E, Tiberghien P, Ferrand C
    A New Human CD20 Spliced mRNA as a Potential Molecular Marker for the Follow-up of B-Cell Malignancies.
    Blood, 2008; 112(suppl): 1479.
Date de mise à jour : 07 avril 2009
information de bas de page Valid XHTML 1.0 Transitional